Francisco Javier Dolcet Roca

Bergadà L; Pallares J; Arcidiacono MV; Cardus A; Santacana M; Valls J; Cao G; Fernàndez E; Dolcet X; Dusso AS; Matias-Guiu X

Role of local bioactivation of vitamin D by CYP27A1 and CYP2R1 in the control of cell growth in normal endometrium and endometrial carcinoma

LABORATORY INVESTIGATION 94 608-622. 01/06/2014.

[doi:10.1038/labinvest.2014.57]

Eritja N; Domingo M; Dosil MA; Mirantes C; Santacana M; Valls J; Llombart-Cussac A; Matias-Guiu X; Dolcet X

Combinatorial Therapy Using Dovitinib and ICI182.780 (Fulvestrant) Blocks Tumoral Activity of Endometrial Cancer Cells

MOLECULAR CANCER THERAPEUTICS 13 776-787. 01/04/2014.

[doi:10.1158/1535-7163.MCT-13-0794]

Bergadà L; Yeramian A; Sorolla A; Matias-Guiu X; Dolcet X

Antioxidants Impair Anti-Tumoral Effects of Vorinostat, but Not Anti-Neoplastic Effects of Vorinostat and Caspase-8 Downregulation

PLOS ONE 9 -. 20/03/2014.

[doi:10.1371/journal.pone.0092764]

Maiques O; Santacana M; Valls J; Pallares J; Mirantes C; Gatius S; García Dios DA; Amant F; Pedersen HC; Dolcet X; Matias-Guiu X

Optimal protocol for PTEN immunostaining; role of analytical and preanalyticat variables in PTEN staining in normal and neoplastic endometrial, breast, and prostatic tissues

HUMAN PATHOLOGY 45 522-532. 01/03/2014.

[doi:10.1016/j.humpath.2013.10.018]

Bergada, L; Santacana, M; Garcia, V; Carceller, JA; Dolcet, X; Matias-Guiu, X

Role of Y-H2AX Expression in Prediction of Radiation Resistance in Endometrial Carcinoma

LABORATORY INVESTIGATION 94 276-276. 01/02/2014.

Santacana, M; Maiques, O; Valls, J; Gatius, S; Lopez-Garcia, MA; Palacios, J; Dolcet, X; Matias-Guiu, X

Immunohistochemical Profiling in Assessing Histological Type in Endometrial Carcinoma

Modern Pathology 27 304-304. 01/02/2014.

Mirantes C; Espinosa I; Ferrer I; Dolcet X; Prat J; Matias-Guiu X

Epithelial-to-mesenchytnal transition and stem cells in endometrial cancer

HUMAN PATHOLOGY 44 1973-1981. 01/10/2013.

[doi:10.1016/j.humpath.2013.04.009]

Eritja, Nuria; Dolcet, Xavier; Matias-Guiu, Xavier

Three-dimensional epithelial cultures: a tool to model cancer development and progression

HISTOLOGY AND HISTOPATHOLOGY 28 1245-1256. 01/10/2013.

[doi:10.14670/HH-28.1245]

Bergadà L; Sorolla A; Yeramian A; Eritja N; Mirantes C; Matias-Guiu X; Dolcet X

Combination of Vorinostat and caspase-8 inhibition exhibits high anti-tumoral activity on endometrial cancer cells

MOLECULAR ONCOLOGY 7 763-775. 01/08/2013.

[doi:10.1016/j.molonc.2013.03.003]

Eritja N; Mirantes C; Llobet D; Yeramian A; Bergadà L; Dosil MA; Domingo M; Matias-Guiu X; Dolcet X

Long-Term Estradiot Exposure Is a Direct Mitogen for Insulin/EGF-Primed Endometriat Cells and Drives PTEN Loss-Induced Hyperplasic Growth

AMERICAN JOURNAL OF PATHOLOGY 183 277-287. 01/07/2013.

[doi:10.1016/j.ajpath.2013.03.008]

Mirantes C; Eritja N; Dosil MA; Santacana M; Pallares J; Gatius S; Bergadà L; Maiques O; Matias-Guiu X; Dolcet X

An inducible knockout mouse to model the cell-autonomous role of PTEN in initiating endometrial, prostate and thyroid neoplasias

DISEASE MODELS & MECHANISMS 6 710-720. 01/05/2013.

[doi:10.1242/dmm.011445]

Yeramian A; Moreno-Bueno G; Dolcet X; Catasus L; Abal M; Colas E; Reventos J; Palacios J; Prat J; Matias-Guiu X

Endometrial carcinoma: molecular alterations involved in tumor development and progression

ONCOGENE 32 403-413. 24/01/2013.

[doi:10.1038/onc.2012.76]